HROW250117P48000
- 7.30
- 0.000.00%
Harrow Newsroom
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $69
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Craig-Hallum Sticks to Its Buy Rating for Harrow Health (HROW)
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Lake Street Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $55
Harrow Health's Strategic Transformation and Growth Potential Underscore Buy Rating
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Lake Street Releases a Buy Rating on Harrow Health (HROW)
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Raises Target Price to $73